Literature DB >> 11058172

Anti-inflammatories for cardiovascular disease.

J L Masferrer1, P Needleman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11058172      PMCID: PMC34058          DOI: 10.1073/pnas.240459597

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  14 in total

1.  Sulindac inhibits neointimal formation after arterial injury in wild-type and apolipoprotein E-deficient mice.

Authors:  E D Reis; M Roque; H Dansky; J T Fallon; J J Badimon; C Cordon-Cardo; S J Shiff; E A Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

2.  The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis.

Authors:  G Steinbach; P M Lynch; R K Phillips; M H Wallace; E Hawk; G B Gordon; N Wakabayashi; B Saunders; Y Shen; T Fujimura; L K Su; B Levin; L Godio; S Patterson; M A Rodriguez-Bigas; S L Jester; K L King; M Schumacher; J Abbruzzese; R N DuBois; W N Hittelman; S Zimmerman; J W Sherman; G Kelloff
Journal:  N Engl J Med       Date:  2000-06-29       Impact factor: 91.245

3.  Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial.

Authors:  L S Simon; A L Weaver; D Y Graham; A J Kivitz; P E Lipsky; R C Hubbard; P C Isakson; K M Verburg; S S Yu; W W Zhao; G S Geis
Journal:  JAMA       Date:  1999-11-24       Impact factor: 56.272

4.  PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs.

Authors:  T C He; T A Chan; B Vogelstein; K W Kinzler
Journal:  Cell       Date:  1999-10-29       Impact factor: 41.582

5.  Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors.

Authors:  J L Masferrer; K M Leahy; A T Koki; B S Zweifel; S L Settle; B M Woerner; D A Edwards; A G Flickinger; R J Moore; K Seibert
Journal:  Cancer Res       Date:  2000-03-01       Impact factor: 12.701

Review 6.  Atherosclerosis.

Authors:  A J Lusis
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

Review 7.  The value of apolipoprotein E knockout mice for studying the effects of dietary fat and cholesterol on atherogenesis.

Authors:  J Osada; J Joven; N Maeda
Journal:  Curr Opin Lipidol       Date:  2000-02       Impact factor: 4.776

8.  Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines.

Authors:  J T Lim; G A Piazza; E K Han; T M Delohery; H Li; T S Finn; R Buttyan; H Yamamoto; G J Sperl; K Brendel; P H Gross; R Pamukcu; I B Weinstein
Journal:  Biochem Pharmacol       Date:  1999-10-01       Impact factor: 5.858

9.  Pharmacokinetics of aspirin and salicylate in relation to inhibition of arachidonate cyclooxygenase and antiinflammatory activity.

Authors:  G A Higgs; J A Salmon; B Henderson; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

10.  Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration.

Authors:  C P Armstrong; A L Blower
Journal:  Gut       Date:  1987-05       Impact factor: 23.059

View more
  2 in total

Review 1.  Therapeutic potential of oral antiproliferative agents in the prevention of coronary restenosis.

Authors:  Pramod Kuchulakanti; Ron Waksman
Journal:  Drugs       Date:  2004       Impact factor: 9.546

2.  Nonsteroidal anti-inflammatory drug choice and adverse outcomes in clopidogrel users: A retrospective cohort study.

Authors:  Young Hee Nam; Colleen M Brensinger; Warren B Bilker; Charles E Leonard; Scott E Kasner; Tilo Grosser; Xuanwen Li; Sean Hennessy
Journal:  PLoS One       Date:  2018-03-14       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.